Ketamine Government Contracts

AI Summary

The Department of Defense is seeking industry collaboration to develop and manufacture an analgesic ketamine product for battlefield use. This RFI addresses the requirement for Tactical Combat Casualty Care solutions for severe pain management. Various formulations, including autoinjectors and topical applications, wil…

AI Summary

The OPMED WPAC PMO is seeking industry collaboration to develop and manufacture an FDA-approved analgesic ketamine product for battlefield use. This Sources Sought notice invites proposals for various forms of ketamine administration, including autoinjectors and topical applications, with plans to issue a formal RFP in…

AI Summary

The National Institutes of Health seeks proposals for tritium labeled ketamine metabolites, specifically R-ketamine, S-ketamine, and RR-HNK. This project aims to support pharmacological studies and requires 5 mCi of each compound for autoradiography work. The contract period is five months from the award date.

AI Summary

The Department of Defense is seeking potential sources to provide Naloxone oral syringes and other compounded pharmaceuticals for Brooke Army Medical Center. This Sources Sought Notice is for information gathering and does not constitute a solicitation. Responses are due by 10:00 AM CST on July 24, 2025, and should inc…

AI Summary

The Department of Defense's Defense Health Agency is seeking sources for non-clinical intramuscular ketamine, with a submission deadline of June 13, 2025. This opportunity falls under NAICS Code 325412. Interested bidders should refer to Attachment 1 for the Request for Information (RFI) to understand the requirements …

AI Summary

The Department of Defense's Defense Health Agency is seeking sources for a 50 mg Ketamine Autoinjector, with a response deadline of June 13, 2025. This opportunity falls under NAICS Code 325412. Interested bidders should refer to Attachment 1 for the Request for Information (RFI) to understand the requirements and subm…